A randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar depression

被引：0
|
作者：
Tohen, M. [1 ]
McDonnell, D. P. [2 ]
Case, M. [2 ]
Kanba, S. [3 ]
Ha, K. [4 ]
Fang, Y. [5 ]
Katagiri, H. [6 ]
Gomez, J. C. [2 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] Kyushu Univ, Fukuoka 812, Japan
[4] Seoul Natl Univ, Seoul, South Korea
[5] Eli Lilly Japan KK, Kobe, Hyogo, Japan
[6] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China
来源：
BIPOLAR DISORDERS | 2011年 / 13卷
关键词：
olanzapine; bipolar depression; placebo;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression
    Tohen, Mauricio
    McDonnell, David P.
    Case, Michael
    Kanba, Shigenobu
    Ha, Kyooseob
    Fang, Yi Ru
    Katagiri, Hideaki
    Gomez, Juan-Carlos
    BRITISH JOURNAL OF PSYCHIATRY, 2012, 201 (05) : 376 - 382
  • [2] Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study
    Hideaki Katagiri
    Mauricio Tohen
    David P McDonnell
    Shinji Fujikoshi
    Michael Case
    Shigenobu Kanba
    Michihiro Takahashi
    Juan-Carlos Gomez
    BMC Psychiatry, 13
  • [3] Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
    Wang, Gang
    Cheng, Yan
    Wang, Jia Ning
    Wu, Sheng Hu
    Xue, Hai Bo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 2077 - 2087
  • [4] Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study
    Katagiri, Hideaki
    Tohen, Mauricio
    McDonnell, David P.
    Fujikoshi, Shinji
    Case, Michael
    Kanba, Shigenobu
    Takahashi, Michihiro
    Gomez, Juan-Carlos
    BMC PSYCHIATRY, 2013, 13
  • [5] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S92 - S92
  • [6] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    E Sherwood Brown
    John Park
    Christine E Marx
    Linda S Hynan
    Claire Gardner
    Domingo Davila
    Alyson Nakamura
    Prabha Sunderajan
    Alexander Lo
    Traci Holmes
    Neuropsychopharmacology, 2014, 39 : 2867 - 2873
  • [7] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S299 - S300
  • [8] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    Brown, E. Sherwood
    Park, John
    Marx, Christine E.
    Hynan, Linda S.
    Gardner, Claire
    Davila, Domingo
    Nakamura, Alyson
    Sunderajan, Prabha
    Lo, Alexander
    Holmes, Traci
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (12) : 2867 - 2873
  • [9] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, J
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A16 - A16
  • [10] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S330 - S331
12345